Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 7 | 2025 | 668 | 3.090 |
Why?
|
| Spices | 3 | 2026 | 6 | 1.590 |
Why?
|
| Cardiovascular Diseases | 4 | 2026 | 2190 | 1.120 |
Why?
|
| Vascular Stiffness | 4 | 2025 | 487 | 0.940 |
Why?
|
| Dementia | 2 | 2025 | 328 | 0.810 |
Why?
|
| Postprandial Period | 2 | 2022 | 114 | 0.760 |
Why?
|
| Cardiovascular System | 1 | 2023 | 139 | 0.700 |
Why?
|
| Cognitive Dysfunction | 2 | 2025 | 468 | 0.630 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 147 | 0.590 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 574 | 0.570 |
Why?
|
| Dietary Fats | 1 | 2020 | 308 | 0.540 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 478 | 0.540 |
Why?
|
| Cytokines | 2 | 2023 | 2069 | 0.520 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 1211 | 0.410 |
Why?
|
| Diet | 1 | 2022 | 1278 | 0.410 |
Why?
|
| Monocytes | 2 | 2023 | 539 | 0.310 |
Why?
|
| Sex Factors | 2 | 2025 | 2110 | 0.290 |
Why?
|
| Cross-Over Studies | 2 | 2022 | 610 | 0.280 |
Why?
|
| Risk Factors | 4 | 2025 | 10916 | 0.250 |
Why?
|
| Hypercapnia | 2 | 2023 | 53 | 0.230 |
Why?
|
| Anti-Obesity Agents | 3 | 2015 | 67 | 0.230 |
Why?
|
| Aged | 5 | 2025 | 26212 | 0.200 |
Why?
|
| Phytotherapy | 2 | 2014 | 74 | 0.200 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2024 | 148 | 0.190 |
Why?
|
| Humans | 14 | 2026 | 145750 | 0.180 |
Why?
|
| Male | 8 | 2025 | 72992 | 0.180 |
Why?
|
| Plant Extracts | 2 | 2014 | 188 | 0.180 |
Why?
|
| Pulse Wave Analysis | 1 | 2023 | 267 | 0.170 |
Why?
|
| Nutrition Surveys | 1 | 2023 | 279 | 0.170 |
Why?
|
| Global Health | 1 | 2025 | 403 | 0.170 |
Why?
|
| Blood Pressure | 3 | 2023 | 1782 | 0.170 |
Why?
|
| Postmenopause | 1 | 2023 | 394 | 0.170 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2022 | 143 | 0.170 |
Why?
|
| Leukocyte Count | 1 | 2022 | 318 | 0.170 |
Why?
|
| Meals | 1 | 2022 | 130 | 0.160 |
Why?
|
| Fasting | 1 | 2022 | 279 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 290 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2022 | 376 | 0.150 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 611 | 0.150 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2023 | 235 | 0.150 |
Why?
|
| Female | 6 | 2025 | 79025 | 0.150 |
Why?
|
| Cell Culture Techniques | 1 | 2022 | 375 | 0.140 |
Why?
|
| Microbiota | 1 | 2026 | 730 | 0.140 |
Why?
|
| Testosterone | 1 | 2022 | 416 | 0.140 |
Why?
|
| Cognition | 2 | 2024 | 1271 | 0.140 |
Why?
|
| Middle Aged | 4 | 2025 | 36297 | 0.130 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2026 | 768 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 361 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2023 | 789 | 0.130 |
Why?
|
| Diet, High-Fat | 2 | 2015 | 266 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2023 | 877 | 0.120 |
Why?
|
| Rutin | 1 | 2015 | 4 | 0.120 |
Why?
|
| Organelle Biogenesis | 1 | 2015 | 14 | 0.120 |
Why?
|
| Overweight | 1 | 2020 | 614 | 0.110 |
Why?
|
| Panax | 1 | 2014 | 2 | 0.110 |
Why?
|
| Peripheral Arterial Disease | 1 | 2021 | 507 | 0.110 |
Why?
|
| Adipogenesis | 1 | 2014 | 56 | 0.100 |
Why?
|
| Mitochondria, Muscle | 1 | 2015 | 120 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 192 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 5921 | 0.100 |
Why?
|
| Kidney | 1 | 2021 | 1498 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 875 | 0.100 |
Why?
|
| Nanocapsules | 1 | 2013 | 14 | 0.090 |
Why?
|
| Hypertension | 1 | 2021 | 1276 | 0.090 |
Why?
|
| Obesity | 3 | 2015 | 3118 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2022 | 8075 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1791 | 0.050 |
Why?
|
| Dinoprost | 1 | 2023 | 51 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2023 | 421 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 423 | 0.040 |
Why?
|
| Antioxidants | 1 | 2023 | 550 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2023 | 584 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 1137 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 2525 | 0.030 |
Why?
|
| Adult | 1 | 2022 | 40867 | 0.030 |
Why?
|
| Time Factors | 2 | 2021 | 7133 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 765 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2023 | 1359 | 0.030 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Mitochondrial Size | 1 | 2015 | 4 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2015 | 39 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 34 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2014 | 36 | 0.030 |
Why?
|
| Hydrostatic Pressure | 1 | 2014 | 29 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2014 | 19 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1751 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 2933 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2015 | 211 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 762 | 0.030 |
Why?
|
| Emulsions | 1 | 2013 | 59 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4329 | 0.020 |
Why?
|
| Biomarkers | 1 | 2023 | 4302 | 0.020 |
Why?
|
| Inflammation | 1 | 2023 | 2883 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 3752 | 0.020 |
Why?
|
| Adiposity | 1 | 2015 | 532 | 0.020 |
Why?
|
| Weight Loss | 1 | 2015 | 859 | 0.020 |
Why?
|
| Animals | 3 | 2015 | 38100 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 1736 | 0.020 |
Why?
|
| United States | 1 | 2024 | 16122 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4569 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 5585 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 5223 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 18357 | 0.010 |
Why?
|